Direktorat Registrasi ObatValid

IMFINZI

Claim this product
BPOM Number
DKI1927900349A1
Approved
21 November 2024
Expiry
17 November 2024
Form
LARUTAN KONSENTRAT UNTUK INFUS; 120 mg

About This Registration

IMFINZI is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1927900349A1. Its current registration status is Valid, with the licence valid until 17 November 2024. The product is registered to ASTRAZENECA INDONESIA - INDONESIA. BPOM first approved this registration in November 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 2.4 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

DURVALUMAB

Market Intelligence

Owner Portfolio
ASTRAZENECA INDONESIA - INDONESIA holds 105 BPOM registrations
Manufacturer Scale
ASTRAZENECA INDONESIA - INDONESIA produces 105 registered products
Registration Age
Registered for 6 years, 10 months
Expiry Status
Expired 677 days ago

FDA Cross-Reference

via openFDA
Generic Name
DURVALUMAB
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from ASTRAZENECA INDONESIA - INDONESIA

PULMICORT RESPULES

-DKI2397000868A1
Valid
Approved: Sep 5, 2026CAIRAN INHALASI
View product →

PULMICORT RESPULES

-DKI2397000868B1
Valid
Approved: Sep 5, 2026CAIRAN INHALASI
View product →

QTERN

-LKE26089007
Valid
Approved: Aug 15, 2026TABLET SALUT SELAPUT
View product →

BETALOC ZOK

-DKI2151304214B1
Valid
Approved: Jul 1, 2026TABLET PELEPASAN LAMBAT
View product →

AIRSUPRA

-DKI2604900539A1
Valid
Approved: Jun 2, 2026AEROSOL INHALASI (PRESSURED METERED DOSE INHALER/PMDI)
View product →

Products in the same class

INTIFEN

-DKL8717604710A1
Valid
Approved: Sep 5, 2026TABLET
INTERBAT - INDONESIA
View product →

VOSTRIN

-DKL1033521601A1
Valid
Approved: Mar 18, 2026KAPSUL
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

VOMCERAN

-DKL9911629817B1
Valid
Approved: Jan 6, 2026TABLET SALUT SELAPUT
KALBE FARMA - INDONESIA
View product →

CONJUNCTO

-DKL7803811146A1
Valid
Approved: Nov 29, 2025TETES MATA
CENDO - INDONESIA
View product →

ARGESUN

-DKI2510800844A1
Valid
Approved: Nov 21, 2025SERBUK INJEKSI + PELARUT
PHARMA LABORATORIES - INDONESIA
View product →
1